Newsroom

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2026-1 PLC   GBP 26,410,000.00   MATURING: 20-Jan-2068   ISIN: XS3346959052     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 4.79 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP 95,519.41 PER GBP 25,116,723.80 DENOMINATION  ...

SYDNEY--(BUSINESS WIRE)--After more than a decade of trying to reinvent the condom, Eudaemon Technologies is preparing to scale manufacturing and take the tech worldwide....

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2024-1 PLC   GBP 18,050,000.00   MATURING: 20-Sep-2061   ISIN: XS2819820015     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 5.04 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP 75,955.16 PER GBP 18,980,808.48 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2026-1 PLC   GBP 9,603,000.00   MATURING: 20-Jan-2068   ISIN: XS3346959136     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 5.09 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP 36,910.99 PER GBP 9,133,271.96 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  Re: Atlas Funding 2026-1 PLC   GBP 432,170,000.00   MATURING: 20-Jan-2068   ISIN: XS3346958914     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 4.56 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP 1,487,961.29 PER GBP 411,007,177.02 DENOMINATION  ...

MONTPELLIER, France--(BUSINESS WIRE)--Medincell (Euronext Paris: MEDCL) today announced that it has secured an additional €13.8 million in non-dilutive financing from leading European commercial banks and Bpifrance. This additional financing follows the €28 million in non-dilutive bank financing announced in July 2026, bringing the total amount of non-dilutive financing secured since July 2026 to €41.8 million. The financing has been secured on market terms and does not include any equity-linke...

NORTH CANTON, Ohio--(BUSINESS WIRE)--Feline clinical visits at U.S. veterinary practices grew 2.7 percent year-over-year in the third quarter of 2026, while canine clinical visits fell 3.3 percent, according to Vetsource data reported in CATalyst Council Feline Veterinary Market Insights: Volume VII. Feline clinical visits grew in each of the last twelve quarters, and canine clinical visits fell in eleven of them. Clinical visits are defined as a patient receiving medical care, including both w...

LONDON--(BUSINESS WIRE)--  Re: EUROFIMA   EUR 80,000,000.00   MATURING: 15-Oct-2030   ISIN: XS1307863081     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-Oct-2026 TO 15-Apr-2027 HAS BEEN FIXED AT 3.04 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 15-Apr-2027 WILL AMOUNT TO: EUR 1,231,533.33 PER EUR 80,000,000.00 DENOMINATION  ...

NEW YORK--(BUSINESS WIRE)--Marsh, a leading global professional services firm, today announced that Nicole Delimitros will become President of National Employee Health and Benefits for Marsh Agency, effective January 1, 2027. She will succeed Kate Moher, who will retire from the firm on April 30, 2027. Ms. Delimitros will report to Trindl Reeves, Chief Revenue Officer, Marsh Agency. In her new role, Ms. Delimitros will help set the strategic direction for Marsh Agency’s National Employee Health...

AUSTIN, Texas--(BUSINESS WIRE)--The Texas Economic Development Council (TEDC) today announced that its Board of Directors has appointed Bill Cork as the organization’s next President and CEO, effective November 1, 2026. Cork will succeed Carlton Schwab, who will retire after serving as TEDC’s President and CEO since February 1, 1999. During Schwab’s nearly 28‑year tenure, the TEDC grew into the nation’s largest state association of economic development professionals and a recognized leader in p...